Correlation Between NYSE Composite and Enanta Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Enanta Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Enanta Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Enanta Pharmaceuticals, you can compare the effects of market volatilities on NYSE Composite and Enanta Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Enanta Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Enanta Pharmaceuticals.
Diversification Opportunities for NYSE Composite and Enanta Pharmaceuticals
0.04 | Correlation Coefficient |
Significant diversification
The 3 months correlation between NYSE and Enanta is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Enanta Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enanta Pharmaceuticals and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Enanta Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enanta Pharmaceuticals has no effect on the direction of NYSE Composite i.e., NYSE Composite and Enanta Pharmaceuticals go up and down completely randomly.
Pair Corralation between NYSE Composite and Enanta Pharmaceuticals
Assuming the 90 days trading horizon NYSE Composite is expected to generate 6.88 times less return on investment than Enanta Pharmaceuticals. But when comparing it to its historical volatility, NYSE Composite is 6.65 times less risky than Enanta Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Enanta Pharmaceuticals is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 585.00 in Enanta Pharmaceuticals on December 29, 2024 and sell it today you would earn a total of 1.00 from holding Enanta Pharmaceuticals or generate 0.17% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
NYSE Composite vs. Enanta Pharmaceuticals
Performance |
Timeline |
NYSE Composite and Enanta Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Enanta Pharmaceuticals
Pair trading matchups for Enanta Pharmaceuticals
Pair Trading with NYSE Composite and Enanta Pharmaceuticals
The main advantage of trading using opposite NYSE Composite and Enanta Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Enanta Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enanta Pharmaceuticals will offset losses from the drop in Enanta Pharmaceuticals' long position.NYSE Composite vs. Cimpress NV | NYSE Composite vs. NorthWestern | NYSE Composite vs. BOS Better Online | NYSE Composite vs. California Water Service |
Enanta Pharmaceuticals vs. Monte Rosa Therapeutics | Enanta Pharmaceuticals vs. Design Therapeutics | Enanta Pharmaceuticals vs. Werewolf Therapeutics | Enanta Pharmaceuticals vs. Ikena Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |